Predictors of early treatment discontinuation and severe anemia in a Brazilian cohort of hepatitis C patients treated with first-generation protease inhibitors

The aim of this study was to determine risk factors for adverse events (AE)-related treatment discontinuation and severe anemia among patients with chronic hepatitis C virus (HCV) genotype 1 infection, treated with first-generation protease inhibitor (PI)-based therapy. We included all patients who...

Descripción completa

Detalles Bibliográficos
Autores principales: Miotto, N., Mendes, L.C., Zanaga, L.P., Goncales, E.S.L., Lazarini, M.S.K., Pedro, M.N., Goncales, F.L., Stucchi, R.S.B., Vigani, A.G.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Associação Brasileira de Divulgação Científica 2016
Materias:
Clinical Investigation
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4926529/
https://www.ncbi.nlm.nih.gov/pubmed/27356107
http://dx.doi.org/10.1590/1414-431X20165300

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4926529/
https://www.ncbi.nlm.nih.gov/pubmed/27356107
http://dx.doi.org/10.1590/1414-431X20165300

Ejemplares similares